Åsa Kronblad

789 total citations
9 papers, 637 citations indexed

About

Åsa Kronblad is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Åsa Kronblad has authored 9 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Åsa Kronblad's work include Cancer, Hypoxia, and Metabolism (7 papers), Cancer-related Molecular Pathways (5 papers) and Estrogen and related hormone effects (3 papers). Åsa Kronblad is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Cancer-related Molecular Pathways (5 papers) and Estrogen and related hormone effects (3 papers). Åsa Kronblad collaborates with scholars based in Sweden, Ireland and United States. Åsa Kronblad's co-authors include Göran Landberg, Lisa Rydén, Karin Jirström, Maria Stendahl, Sven Påhlman, Elise Nilsson, Annika Jögi, Siv Beckman, Stefan O. Emdin and Nils‐Olof Bengtsson and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Åsa Kronblad

9 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Åsa Kronblad Sweden 7 359 331 319 124 112 9 637
Eva Schuster Austria 15 281 0.8× 486 1.5× 333 1.0× 132 1.1× 87 0.8× 37 867
Julia Bárdos United Kingdom 10 366 1.0× 536 1.6× 179 0.6× 73 0.6× 60 0.5× 13 777
Brent Rupnow United States 10 235 0.7× 353 1.1× 180 0.6× 63 0.5× 64 0.6× 19 658
Jose Bonet Spain 4 311 0.9× 540 1.6× 152 0.5× 128 1.0× 137 1.2× 4 801
Enrique Alvarez Sotomayor United States 7 289 0.8× 411 1.2× 220 0.7× 34 0.3× 78 0.7× 9 590
Mamunur Rashid United Kingdom 14 220 0.6× 491 1.5× 248 0.8× 69 0.6× 89 0.8× 19 817
Fons Elstrodt Netherlands 8 146 0.4× 494 1.5× 340 1.1× 118 1.0× 59 0.5× 9 691
Satoko Yamamoto Japan 18 148 0.4× 301 0.9× 213 0.7× 58 0.5× 86 0.8× 35 648
Marc Díez Spain 6 431 1.2× 459 1.4× 510 1.6× 85 0.7× 285 2.5× 15 1.1k
John Ojeifo United States 10 211 0.6× 416 1.3× 250 0.8× 58 0.5× 25 0.2× 19 621

Countries citing papers authored by Åsa Kronblad

Since Specialization
Citations

This map shows the geographic impact of Åsa Kronblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Kronblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Kronblad more than expected).

Fields of papers citing papers by Åsa Kronblad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsa Kronblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Kronblad. The network helps show where Åsa Kronblad may publish in the future.

Co-authorship network of co-authors of Åsa Kronblad

This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Kronblad. A scholar is included among the top collaborators of Åsa Kronblad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Kronblad. Åsa Kronblad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Brennan, Donal J., Karin Jirström, Åsa Kronblad, et al.. (2006). CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance. Clinical Cancer Research. 12(21). 6421–6431. 107 indexed citations
2.
Brennan, Donal J., Åsa Kronblad, Karin Jirström, et al.. (2006). Carbonic anhydrase IX is a new independent prognostic marker in pre-menopausal breast cancer patients with 1 to 3 positive lymph nodes. Cancer Research. 66. 847–847. 3 indexed citations
3.
Kronblad, Åsa, Ingrid Hedenfalk, Elise Nilsson, Sven Påhlman, & Göran Landberg. (2005). ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα: a combination therapy potentially targeting hypoxic and dormant tumor cells. Oncogene. 24(45). 6835–6841. 40 indexed citations
4.
Kronblad, Åsa, Karin Jirström, Lisa Rydén, Bo Nordenskjöld, & Göran Landberg. (2005). Hypoxia inducible factor‐1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response. International Journal of Cancer. 118(10). 2609–2616. 68 indexed citations
5.
Jirström, Karin, Maria Stendahl, Lisa Rydén, et al.. (2005). Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with Cyclin D1 Gene Amplification. Cancer Research. 65(17). 8009–8016. 107 indexed citations
6.
Hedenfalk, Ingrid, et al.. (2005). Microarray-based Analyses of Hypoxia-induced Transcriptional Changes in Breast Cancer Cell Lines. Lund University Publications (Lund University). 2(2). 83–95. 1 indexed citations
7.
Kronblad, Åsa, et al.. (2004). Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.. PubMed. 17(4). 311–8. 10 indexed citations
8.
Stendahl, Maria, Åsa Kronblad, Lisa Rydén, et al.. (2004). Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. British Journal of Cancer. 90(10). 1942–1948. 136 indexed citations
9.
Kronblad, Åsa, Annika Jögi, Elise Nilsson, et al.. (2003). Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.. PubMed. 63(7). 1441–4. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026